newsfilter
← Latest News
PR Newswire·

MicroVention Announces First U.S. Patient Treated with FRED™ X™ Flow Diverter Featuring X Technology

ALISO VIEJO, Calif., Feb. 22, 2022 /PRNewswire/ -- MicroVention, Inc., a subsidiary of Terumo and a global neurovascular company, announced the first U.S. clinical case of its next generation Flow Diverter, the FRED X device, at Thomas Jefferson Universi